Sponsors / AARD
AARD

Aardvark Therapeutics, Inc.

Company identity checked against sources

See the trials and registry edits we have linked to this sponsor, the company or organization running a study. Choose “Follow company” to add it to your watchlist and find its recorded changes in your dashboard.

Follow company
6Trials in this database
14Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Study to Evaluate ARD-101 in Adults With ObesityNCT05121441AARDPhase 2Completed2022-11-09Actual
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434AARDPhase 2Completed2024-09-24Actual
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847AARDPhase 2Completed2023-02-03Actual
A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderNCT06126653AARDPhase 2Completed2025-01-13Actual
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861AARDPhase 3Terminated2026-05-07Actual
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034AARDPhase 3Terminated2026-04-15Actual

Latest recorded trial changes

A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome

NCT05153434 · Aardvark Therapeutics, Inc.

Primary outcomes · main study measuresText edit · unverified significance
− Previous value

measure: Incidence of Treatment-Emergent Adverse Events (TEAE)

+ Updated value

measure: Incidence of Treatment Emergent Adverse Events (TEAE)

Check registry source · The saved outcome text may be shortened. Check the source for full wording.